Carregant...
Light activated, In situ Forming Gel for Sustained Suprachoroidal Delivery of Bevacizumab
PURPOSE: To develop a light activated polycaprolactone dimethacrylate and hydroxyethyl methacrylate based gel network that sustains the release of stable, active bevacizumab (an anti-VEGF antibody used to treat choroidal neovascularization) and to assess sustained ex vivo delivery in rabbit eyes and...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4003910/ https://ncbi.nlm.nih.gov/pubmed/23734705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp300716t |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|